Get the Stockscreener App
307.08
3.19%
9.48
After Hours:
305.75
-1.33
-0.43%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $307.08, with a volume of 2.80M.
It is up +3.19% in the last 24 hours and up +11.63% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$297.60
Open:
$299.8
24h Volume:
2.80M
Relative Volume:
1.10
Market Cap:
$117.79B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
35.57
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
+4.72%
1M Performance:
+11.63%
6M Performance:
-6.76%
1Y Performance:
-20.93%
1-Day Range:
$299.36
$309.68
1-Week Range:
$290.01
$309.68
52-Week Range:
$267.00
$392.55
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-26 | Initiated | Barclays | Overweight |
| Aug-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-28-26 | Resumed | UBS | Buy |
| Jul-09-26 | Initiated | BMO Capital Markets | Outperform |
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
19,374 Stryker Corporation $SYK Shares Acquired by Eagle Rock Investment Company LLC - MarketBeat
Colorado Company donates $30,000 to Stryker Tragedy victims - KSN.com
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Sawyer & Company Inc Purchases New Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stock Sold by Stillwater Wealth Management Group - MarketBeat
Stryker Corp Stock (SYK) Moved Down by 3.70% on Oct 21: What Investors Need To Know - TradingKey
Stryker stock: BTIG cuts target from USD 358.00 to USD 316.00 - AD HOC NEWS
PAHC or SYK: Which Is the Better Value Stock Right Now? - Zacks Investment Research
2 Dividend Stocks to Buy and Hold Forever - The Motley Fool
Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical Accuracy - Yahoo Finance
QV Investors Inc. Makes New Investment in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stake Lifted by Nisa Investment Advisors LLC - MarketBeat
A top medical technology stock is trading at a big discount. Here's why I'm buying - CNBC
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Bank Pictet & Cie Europe AG Sells 8,958 Shares of Stryker Corporation $SYK - MarketBeat
The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services - The Globe and Mail
ETFs Are Net Sellers of Stryker (SYK) on Friday - Yahoo Finance
Barclays targets Stryker stock at USD 375 after robotics deal - ad-hoc-news.de
Is Stryker Corp. (SYK) Positioned for Above-Market Growth? - Yahoo Finance
Value Partners Investments Inc. Makes New $1 Million Investment in Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
2 Industries Beyond AI With Long-Term Demand Drivers for 2027 - Zacks Investment Research
Stryker Corporation $SYK Stock: Talbot Financial LLC Increases Holdings - MarketBeat
Stryker Enters Soft-Tissue Robotics With $400 Million CMR Deal - Zacks Investment Research
Stryker plans $400M investment in CMR Surgical, secures acquisition option - Healthcare IT News
Stryker Corporation $SYK Stock: Generali Investments Management Co LLC Reduces Holdings - MarketBeat
Stryker, Viatris, Flo, Teva, J&J: This Week in Healthcare - Healthcare Digital
Stryker Corporation (SYK) Stock Forecasts - Yahoo Finance
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum? - Zacks Investment Research
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker invests $400M in UK surgical robotics company - Crain's Grand Rapids Business
What Is Stryker (SYK) Really Getting From Its $400 Million Robotics Deal? - Yahoo Finance
Securities Fraud Investigation Into Stryker Corporation - GlobeNewswire
Major medtech business moves from Stryker, STERIS - Today's Medical Developments
Securities Fraud Investigation Into Stryker Corporation - GlobeNewswire
ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell? - Zacks Investment Research
Earnings Preview: What To Expect From Stryker Corporation’s Report - Yahoo Finance
Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance? - Zacks Investment Research
ASML: A Rule Breaker Test of Lasting Leadership - The Motley Fool
3 Reasons Investors Watch Stryker (SYK) - Yahoo Finance
Stryker Announces $400 Million Investment in CMR Surgical With Option for Full Acquisition - Yahoo Finance
China Stretchers and Cots Market Outlook to 2033Ambulance, Emergency, Manual, and Motorized Transport Segments | EMS Investment and Automation Unlock Growth Opportunities - GlobeNewswire Inc.
Australia Stretchers and Cots Market Outlook to 2033Revenue, Volume, Pricing and Company Share Forecast | Segment Growth Opens Investment and Expansion Opportunities - GlobeNewswire Inc.
Stryker (SYK): Near-Term Growth Concerns Overshadow Long-Term Strength - Yahoo Finance
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates - Zacks Investment Research
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp.SYK - GlobeNewswire Inc.
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown? - Zacks Investment Research
Stryker announces next CEO - WOODTV.com
Stryker names President, COO Spencer Stiles as next CEO - WWMT
Stryker (SYK) vs Boston Scientific (BSX): Which is a Better Stock to Buy? - Yahoo Finance
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Stryker Corp Stock (SYK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
Aug 19 '26 |
Sale |
340.10 |
50,000 |
17,005,165 |
2,251,375 |
| King Debra | See Remarks |
Aug 18 '26 |
Sale |
336.30 |
826 |
277,787 |
6,210 |
| Debra King | Officer |
Aug 18 '26 |
Proposed Sale |
336.30 |
826 |
277,786 |
0 |
| STRYKER RONDA E | Director |
Aug 18 '26 |
Proposed Sale |
335.00 |
350,000 |
117,250,000 |
0 |
| STRYKER RONDA E | Director |
Aug 18 '26 |
Sale |
335.90 |
300,000 |
100,770,963 |
2,301,375 |
| Fletcher Robert S | Officer |
May 28 '26 |
Proposed Sale |
305.59 |
4,544 |
1,388,601 |
0 |
| Fletcher Robert S | VP, Chief Legal Officer |
May 28 '26 |
Sale |
306.87 |
4,544 |
1,394,409 |
10,582 |
| STRYKER RONDA E | Director |
May 26 '26 |
Sale |
312.23 |
310,000 |
96,792,669 |
1,924,880 |
| STRYKER RONDA E | Director |
May 26 '26 |
Proposed Sale |
313.00 |
310,000 |
97,030,000 |
0 |
| Fink M Kathryn | VP, Chief HR Officer |
May 11 '26 |
Sale |
283.85 |
5,220 |
1,481,671 |
13,137 |
3.83%
2.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):